Headlines
Bloomberg MarketsNYC Mayor Mamdani Says ICE 'Makes Us Less Safe'Federal ReserveFederal Reserve Board releases results of the 2025 Survey of Consumer Finances, which provides the public and policymakers with detailed insights into the economic condition of American familiesBloomberg MarketsOrban Denies Giving Order for Hungary’s Seizure of Ukraine Gold, Cash ConvoyBloomberg MarketsHungary Needs Significant Deficit Cut For Euro Path, Magyar SaysBloomberg MarketsTwo Ships Hauling US LNG Divert to Europe as Asian Demand EasesBloomberg MarketsTech Chief of $321 Billion Pension Departs After String of ExitsBloomberg MarketsAngelini CEO Marullo di Condojanni on M&A ProspectsBloomberg MarketsHurricane Isaias Reaches Category 3 as It Nears Florida, AlabamaFinancial TimesNobel Peace Prize awarded to human rights pioneer Navi PillayBloomberg MarketsSlovakia Says US Understands Need to Import Russian Oil and GasBloomberg MarketsDelta Demand Looks Good Despite Fuel Prices, Jeffries Analyst SaysBloomberg MarketsStocks Rise as AI Concerns Ease; Dollar Rally PersistsBloomberg MarketsAI Powered Bull Market in S&P, Now It Needs More Building BlocksBloomberg MarketsCanada Employment Falls by 68,300 Amid Public Sector DeclineBloomberg MarketsFrance’s €43 Billion Budget Push Is Big Deal, Fitch Analyst SaysBloomberg MarketsNYC Mayor Mamdani Says ICE 'Makes Us Less Safe'Federal ReserveFederal Reserve Board releases results of the 2025 Survey of Consumer Finances, which provides the public and policymakers with detailed insights into the economic condition of American familiesBloomberg MarketsOrban Denies Giving Order for Hungary’s Seizure of Ukraine Gold, Cash ConvoyBloomberg MarketsHungary Needs Significant Deficit Cut For Euro Path, Magyar SaysBloomberg MarketsTwo Ships Hauling US LNG Divert to Europe as Asian Demand EasesBloomberg MarketsTech Chief of $321 Billion Pension Departs After String of ExitsBloomberg MarketsAngelini CEO Marullo di Condojanni on M&A ProspectsBloomberg MarketsHurricane Isaias Reaches Category 3 as It Nears Florida, AlabamaFinancial TimesNobel Peace Prize awarded to human rights pioneer Navi PillayBloomberg MarketsSlovakia Says US Understands Need to Import Russian Oil and GasBloomberg MarketsDelta Demand Looks Good Despite Fuel Prices, Jeffries Analyst SaysBloomberg MarketsStocks Rise as AI Concerns Ease; Dollar Rally PersistsBloomberg MarketsAI Powered Bull Market in S&P, Now It Needs More Building BlocksBloomberg MarketsCanada Employment Falls by 68,300 Amid Public Sector DeclineBloomberg MarketsFrance’s €43 Billion Budget Push Is Big Deal, Fitch Analyst Says
Home/CNBC Top News
Back
MARKETS:
SPY+0.26%
DIA+0.23%
QQQ-0.14%
IWM+0.29%
GLD-0.40%
USO+1.64%
CNBC Top Newsmarkets

Teva wins FDA approval for monthly schizophrenia injection Weltruza

CNBC Top News
Friday, October 9, 2026 at 1:14 PM
~4 min read

Original Report

Teva has received FDA approval for once monthly injectable schizophrenia drug Weltruza. The announcement sent Teva shares gaining in premarket.

Glass House Analysis

This story reflects the interconnected nature of modern economic systems, where developments in one sector inevitably affect others. Understanding these connections is essential for grasping how policy decisions and market movements translate into real-world outcomes for families, workers, and communities. The economy is not an abstract system of numbers—it's the sum total of decisions about who works, who prospers, and who struggles.

The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.

Enjoyed this analysis?

Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.

No spam. Unsubscribe anytime.

More Stories

Economic Context

S&P 500
+0.26%
Dow Jones
+0.23%
NASDAQ 100
-0.14%
Russell 2000
+0.29%